Comparable stake leader
GLAZER CAPITAL, LLC
SEC ownership of CHIMERIX INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001117480.
Disclosed value leader
GLAZER CAPITAL, LLC
Comparable rows
1/10
Latest evidence
21 Apr 2025
- Parsed ownership sources
-
13D/G and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
GLAZER CAPITAL, LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
1 of 10
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
GLAZER CAPITAL, LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
21 Apr 2025
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001117480
- Issuer location
- Durham, NC
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of CHIMERIX INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GLAZER CAPITAL, LLC
Disclosed value leader
GLAZER CAPITAL, LLC
Comparable rows
1/10
Latest evidence
21 Apr 2025
13D/G
3/4/5
Lead comparable stake: 4.9%
9 rows are not safely comparable across share classes.
13D/G row: GLAZER CAPITAL, LLC
Showing 1-8 of 10 holder rows.
Quick read
GLAZER CAPITAL, LLC leads the comparable SEC ownership view at 4.9%.
1 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GLAZER CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 1
GLAZER CAPITAL, LLC
4.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 10 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GLAZER CAPITAL, LLC |
13D/G
|
4.9%
|
$39,405,593
4,614,238 shares
|
$0 | 10 Apr 2025 |
| CANTEX PHARMACEUTICALS, INC. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$3,343,550
3,500,000 shares
|
— | 14 Sep 2021 |
| Andriole Michael T. |
3/4/5
PRESIDENT AND CEO, Director
|
—
class O/S missing
|
—
900,000 shares
|
— | 21 Apr 2025 |
| Thomas J. Riga |
3/4/5
COO and CCO
|
—
class O/S missing
|
—
325,000 shares
|
— | 21 Apr 2025 |
| Allen S. Melemed |
3/4/5
CHIEF MEDICAL OFFICER
|
—
class O/S missing
|
—
275,000 shares
|
— | 21 Apr 2025 |
| Michael Albert Alrutz |
3/4/5
SVP AND GENERAL COUNSEL
|
—
class O/S missing
|
—
250,000 shares
|
— | 21 Apr 2025 |
| Michelle LaSpaluto |
3/4/5
CHIEF FINANCIAL OFFICER
|
—
class O/S missing
|
—
250,000 shares
|
— | 21 Apr 2025 |
| David Jakeman |
3/4/5
VP OF FINANCE AND ACCOUNTING
|
—
class O/S missing
|
—
65,000 shares
|
— | 21 Apr 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 16 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-17 of 17 reporting-owner rows connected to CHIMERIX INC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
17
Largest Forms 3/4/5 holder
CANTEX PHARMACEUTICALS, INC.
Net 12M change
$0
Latest report
21 Apr 2025
Recent insider transactions for CHIMERIX INC
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.